EVERYTHING
According to Eurekalert, a recent study involving 52 people living with HIV has provided critical insight into why some individuals continue to show detectable viral loads even while on effective long-term ART. The research, which was partially supported by grants from the National Institutes of Health (NIH), suggests that the majority of these persistent traces are caused by defective copies of the virus, offering potential relief and clarity for patients worldwide.
Understanding Non-Suppressible Viremia
Antiretroviral drugs have revolutionized HIV treatment, allowing most individuals to lead long and healthy lives. The primary goal of medication is achieving an undetectable viral load. However, in less than 1% of cases, detectable levels can persist years after starting therapy or may never be suppressed. Investigators examined blood samples from participants who had detectable loads despite taking ART between 2021 and 2025.
The study found that approximately 95% of the detectable viral forms were due to defective copies. These defects primarily involved mutations or deletions in a specific region of the HIV-1 RNA known as the 5’-leader. This region is crucial for orchestrating the production of new virus particles, but when damaged, it prevents the generation of infectious virus.
Implications for Patient Care and Treatment
The findings carry significant clinical weight because they offer a clear explanation for viral persistence that does not necessarily equate to ongoing active infection. Francesco R. Simonetti, M.B.Ch.BD., Ph.D., senior study author at Johns Hopkins University School of Medicine, emphasized the importance of this knowledge.
The new evidence suggests several major benefits for the HIV community and clinical practice:
- It provides reassurance to patients who worry about viral rebound or transmission despite taking effective treatment.
- Clinicians can now use specialized assays to confirm if detectable levels are caused by defective copies released from a few T-cell clones, rather than active replication.
- This confirmation could eliminate the need for extra medications and prevent related complications.
- It may help people living with HIV gain access to surgeries or other procedures, such as hip replacements or organ transplants, and participate in clinical studies if their virus is confirmed to be under control.
Modern ART prevents HIV from infecting new immune system cells, but it cannot retroactively prevent previously infected cells from releasing viral particles. By identifying these defective copies, the research offers a pathway for more precise medical management and improved quality of life for those living with HIV.